Although certain studies have demonstrated the enhanced effectiveness of targeting tumor cells with combinations of chemotherapeutic agents and signal transduction inhibitors (20), the enhancing effects of blockade of the PI3K/Akt pathway on paclitaxel in hypoxic GC cells remains unclear. This evidence concerns the gene AKT1 and neoplasm.